Research progress in autologous regeneration of human corneal endothelial cells

doi:10.3969/j.issn.1674-8115.2023.06.015

Abstract

Abstract:

Human corneal endothelial cells (HCECs) are very important for maintaining corneal transparency, but HCECs remain arrested at the G1 phase after embryonic development and could not proliferate and regenerate in vivo. The density of HCECs decreases spontaneously with corneal development and aging, while systemic factors and corneal diseases can further cause a massive loss to HCECs, lead to corneal opacity and edema and ultimately induce vision impairment. Therefore, the regeneration of HCECs has always been a heated topic in the field of corneal endothelial research. Currently, function restoration of exogenous corneal endothelium mediated by cell therapy and autologous regeneration of endogenous HCECs have made amazing breakthroughs, with endogenous HCECs autologous regeneration being a more convenient and physiological treatment option. This review summarizes and analyzes the strategies and related techniques that are currently applied to the autologous regeneration of HCECs in aspects of operative treatment, gene therapy and pharmacological treatment.

Key words: human corneal endothelial cell (HCEC), cell proliferation, autologous regeneration, operative treatment, gene therapy, pharmacological treatment

CLC Number:

CHEN Jin, FU Yao. Research progress in autologous regeneration of human corneal endothelial cells[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(6): 775-780.

TrendMD

References 42

1	CATALÀ P, THURET G, SKOTTMAN H, et al. Approaches for corneal endothelium regenerative medicine[J]. Prog Retin Eye Res, 2022, 87: 100987.
2	任志超, 李宗义, 谢立信. 人角膜内皮细胞再生的研究进展[J]. 中华眼科杂志, 2022, 58(10): 821-830.
	REN Z C, LI Z Y, XIE L X. Research advances in human corneal endothelial cell regeneration[J]. Chinese Journal of Ophthalmology, 2022, 58(10): 821-830
3	JOYCE N C. Proliferative capacity of corneal endothelial cells[J]. Exp Eye Res, 2012, 95(1): 16-23.
4	SIE N M, YAM G H F, SOH Y Q, et al. Regenerative capacity of the corneal transition zone for endothelial cell therapy[J]. Stem Cell Res Ther, 2020, 11(1): 523.
5	YAM G H, SEAH X, YUSOFF N Z B M, et al. Characterization of human transition zone reveals a putative progenitor-enriched niche of corneal endothelium[J]. Cells, 2019, 8(10): 1244.
6	PRICE M O, MEHTA J S, JURKUNAS U V, et al. Corneal endothelial dysfunction: evolving understanding and treatment options[J]. Prog Retin Eye Res, 2021, 82: 100904.
7	DUNKER S L, DICKMAN M M, WISSE R P L, et al. Descemet membrane endothelial keratoplasty versus ultrathin descemet stripping automated endothelial keratoplasty: a multicenter randomized controlled clinical trial[J]. Ophthalmology, 2020, 127(9): 1152-1159.
8	DIRISAMER M, YEH R Y, VAN DIJK K, et al. Recipient endothelium may relate to corneal clearance in descemet membrane endothelial transfer[J]. Am J Ophthalmol, 2012, 154(2): 290-296.e1.
9	SHAH R D, RANDLEMAN J B, GROSSNIKLAUS H E. Spontaneous corneal clearing after Descemet's stripping without endothelial replacement[J]. Ophthalmology, 2012, 119(2): 256-260.
10	BORKAR D S, VELDMAN P, COLBY K A. Treatment of fuchs endothelial dystrophy by descemet stripping without endothelial keratoplasty[J]. Cornea, 2016, 35(10): 1267-1273.
11	ONG TONE S, KOCABA V, BÖHM M, et al. Fuchs endothelial corneal dystrophy: the vicious cycle of Fuchs pathogenesis[J]. Prog Retin Eye Res, 2021, 80: 100863.
12	FUCHSLUGER T A, JURKUNAS U, KAZLAUSKAS A, et al. Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage[J]. Gene Ther, 2011, 18(8): 778-787.
13	KAMPIK D, BASCHE M, GEORGIADIS A, et al. Modulation of contact inhibition by ZO-1/ZONAB gene transfer: a new strategy to increase the endothelial cell density of corneal grafts[J]. Invest Ophthalmol Vis Sci, 2019, 60(8): 3170-3177.
14	TOYONO T, USUI T, VILLARREAL G Jr, et al. MicroRNA-29b overexpression decreases extracellular matrix mRNA and protein production in human corneal endothelial cells[J]. Cornea, 2016, 35(11): 1466-1470.
15	HU J X, RONG Z Y, GONG X, et al. Oligonucleotides targeting TCF4 triplet repeat expansion inhibit RNA foci and mis-splicing in Fuchs' dystrophy[J]. Hum Mol Genet, 2018, 27(6): 1015-1026.
16	HU J X, SHEN X L, RIGO F, et al. Duplex RNAs and ss-siRNAs block RNA foci associated with fuchs' endothelial corneal dystrophy[J]. Nucleic Acid Ther, 2019, 29(2): 73-81.
17	ZAROUCHLIOTI C, SANCHEZ-PINTADO B, HAFFORD TEAR N J, et al. Antisense therapy for a common corneal dystrophy ameliorates TCF4 repeat expansion-mediated toxicity[J]. Am J Hum Genet, 2018, 102(4): 528-539.
18	RONG Z Y, GONG X, HULLEMAN J D, et al. Trinucleotide repeat-targeting dCas9 as a therapeutic strategy for fuchs' endothelial corneal dystrophy[J]. Transl Vis Sci Technol, 2020, 9(9): 47.
19	UEHARA H, ZHANG X H, PEREIRA F, et al. Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy[J]. Elife, 2021, 10: e55637.
20	赵靖, 谢立信, 史伟云, 等. 表皮生长因子对猫角膜内皮细胞DNA合成的影响[J]. 眼科研究, 2002, 20(5): 419-422.
	ZHAO J, XIE L X, SHI W Y, et al. Effects of epidermal growth factor on wound healing in cat corneal endothelial culture[J]. Chinese Ophthalmic Research, 2002, 20(5): 419-422.
21	PETSOGLOU C, WEN L, HOQUE M, et al. Effects of human platelet lysate on the growth of cultured human corneal endothelial cells[J]. Exp Eye Res, 2021, 208: 108613.
22	LEE J G, JUNG E, HEUR M. Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium[J]. J Biol Chem, 2018, 293(10): 3758-3769.
23	钟一声. 生长因子与角膜内皮细胞[J]. 眼科研究, 1999, 17(4): 314-316.
	ZHONG Y S. Growth factors and corneal endothelium[J]. Chin Ophthal Res, 1999, 17(4): 314-316.
24	XIA X, BABCOCK J P, BLABER S I, et al. Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application[J]. PLoS One, 2012, 7(11): e48210.
25	SYED Z A, RAPUANO C J. Rho kinase (ROCK) inhibitors in the management of corneal endothelial disease[J]. Curr Opin Ophthalmol, 2021, 32(3): 268-274.
26	OKUMURA N, UENO M, KOIZUMI N, et al. Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor[J]. Invest Ophthalmol Vis Sci, 2009, 50(8): 3680-3687.
27	PIPPARELLI A, ARSENIJEVIC Y, THURET G, et al. ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells[J]. PLoS One, 2013, 8(4): e62095.
28	KOIZUMI N, OKUMURA N, UENO M, et al. Rho-associated kinase inhibitor eye drop treatment as a possible medical treatment for Fuchs corneal dystrophy[J]. Cornea, 2013, 32(8): 1167-1170.
29	OKUMURA N, KOIZUMI N, KAY E P, et al. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing[J]. Invest Ophthalmol Vis Sci, 2013, 54(4): 2493-2502.
30	OKUMURA N, INOUE R, OKAZAKI Y, et al. Effect of the Rho kinase inhibitor Y-27632 on corneal endothelial wound healing[J]. Invest Ophthalmol Vis Sci, 2015, 56(10): 6067-6074.
31	SCHLÖTZER-SCHREHARDT U, ZENKEL M, STRUNZ M, et al. Potential functional restoration of corneal endothelial cells in Fuchs endothelial corneal dystrophy by ROCK inhibitor (ripasudil)[J]. Am J Ophthalmol, 2021, 224: 185-199.
32	MOLONEY G, PETSOGLOU C, BALL M, et al. Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical ripasudil[J]. Cornea, 2017, 36(6): 642-648.
33	SANTERRE K, CORTEZ GHIO S, PROULX S. TGF-β-mediated modulation of cell-cell interactions in postconfluent maturing corneal endothelial cells[J]. Invest Ophthalmol Vis Sci, 2022, 63(11): 3.
34	MIN S H, LEE T I, CHUNG Y S, et al. Transforming growth factor-β levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes[J]. Korean J Ophthalmol, 2006, 20(3): 162-165.
35	KIM T Y, KIM W I, SMITH R E, et al. Differential activity of TGF-β2 on the expression of p27Kip1 and Cdk4 in actively cycling and contact inhibited rabbit corneal endothelial cells[J]. Mol Vis, 2001, 7: 261-270.
36	WILSON S E, SHIJU T M, SAMPAIO L P, et al. Corneal fibroblast collagen type Ⅳ negative feedback modulation of TGF β: a fibrosis modulating system likely active in other organs[J]. Matrix Biol, 2022, 109: 162-172.
37	SMERINGAIOVA I, UTHEIM T P, JIRSOVA K. Ex vivo expansion and characterization of human corneal endothelium for transplantation: a review[J]. Stem Cell Res Ther, 2021, 12(1): 554.
38	OKUMURA N, HASHIMOTO K, KITAHARA M, et al. Activation of TGF-β signaling induces cell death via the unfolded protein response in Fuchs endothelial corneal dystrophy[J]. Sci Rep, 2017, 7(1): 6801.
39	LIU C L, MIYAJIMA T, MELANGATH G, et al. Ultraviolet a light induces DNA damage and estrogen-DNA adducts in Fuchs endothelial corneal dystrophy causing females to be more affected[J]. Proc Natl Acad Sci USA, 2020, 117(1): 573-583.
40	KIM E C, MENG H, JUN A S. N-Acetylcysteine increases corneal endothelial cell survival in a mouse model of Fuchs endothelial corneal dystrophy[J]. Exp Eye Res, 2014, 127: 20-25.
41	ZIAEI A, SCHMEDT T, CHEN Y, et al. Sulforaphane decreases endothelial cell apoptosis in Fuchs endothelial corneal dystrophy: a novel treatment[J]. Invest Ophthalmol Vis Sci, 2013, 54(10): 6724-6734.
42	KIM E C, TOYONO T, BERLINICKE C A, et al. Screening and characterization of drugs that protect corneal endothelial cells against unfolded protein response and oxidative stress[J]. Invest Ophthalmol Vis Sci, 2017, 58(2): 892-900.

[1]	ZHU Zijun, QIAN Yife, LI Qianyu, LI Songling, QIN Wenli, LIU Yanfeng. Anaphase-promoting complex subunit 10 promotes hepatocellular carcinoma progression through regulation of the PI3K-AKT-mTOR signaling pathway [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(9): 1171-1182.
[2]	HE Suhui, ZHAO Yinlong, CHANG Alex Chia Yu. Effects of telomerase gene therapy on pressure overload-induced heart failure in mice [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(8): 949-956.
[3]	GAO Xinjie, LIU Yan, WANG Dawei. Research progress and considerations for thalassemia gene therapy [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(5): 540-548.
[4]	XU Muxin, LIU Xian, JIANG Lishan, SUN Qing. Promotion of Nd:YAP laser biostimulation on the proliferation and osteogenic differentiation of human periodontal ligament cells through WNT/β-catenin signaling pathway [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(5): 562-569.
[5]	CHEN Yinan, ZHENG Yang, ZENG Hanlin, LEI Ming. Mechanism of Fas-associated protein with death domain in promoting proliferation of head and neck squamous cell carcinoma cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(4): 404-414.
[6]	ZHANG Xianzhou, DU Fenglin, WU Lei, REN Yizhe, ZHAO Mingna, LOU Jiatao. Mechanistic study of OGT-promoted non-small cell lung cancer proliferation via the ERK signaling pathway [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(10): 1288-1297.
[7]	LI Xiang, WEI Ming, WU Wenxi, LUO Xiaoqin, YAO Biao, WU Siyu. Inhibitory effect of rutin on the growth and metastasis of osteosarcoma in vitro and in vivo [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(1): 20-28.
[8]	SUN Chenwei, HAI Wangxi, QU Qian, XI Yun. [¹⁸F]F-FMISO and [¹⁸F]F-FLT PET/CT dual-nuclide imaging for in vivo prediction of drug resistance in pancreatic cancer [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2025, 45(1): 60-68.
[9]	SHI Lingling, CHENG Yanyong, ZHANG Lei. Effects of sevoflurane exposure on proliferation and differentiation of primary oligodendrocytes [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(9): 1115-1123.
[10]	CHEN Shentse, CHEN Yiming, WANG Fan, ZHANG Mengke, YANG Weichieh, LÜ Dongbin, HONG Wu. Advances in dietary interventions for the treatment of depression-related symptoms [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(8): 1050-1055.
[11]	TAN Lu, SHEN Shaoming, HE Ping. Function and mechanism study of hypoxia-induced long non-coding RNA 68 in hepatocellular carcinoma [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(6): 702-712.
[12]	CAI Renjie, XU Ming. KHSRP regulates the responsiveness of prostate cancer cells to androgens through ANK3 [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(4): 417-426.
[13]	AN Junyi, CHEN Biying, CHEN Xunrui, YIN Shanshan, BIAN Zhouliang, LIU Feng. SFXN3 expression in head and neck squamous cell carcinoma and its effect on cell proliferation [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(4): 427-434.
[14]	LI Huxiao, LI Xiaotian, ZHAO Xuri, ZHANG Huanyu, ZHOU Wei, SONG Zhongchen. Effects of gingipain extract on the biological characteristics of oral squamous cell carcinoma cell HN6 [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(2): 161-168.
[15]	LUO Lange, ZHENG Chao, LEI Ming. Promotive effect of cancer-testis antigen CT57 on proliferation, invasion, migration and epithelial-mesenchymal transition of liver cancer cells [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024, 44(11): 1335-1346.